Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-04 van Houte Hans Chief Financial Officer Sale 10b5-1 −3,300 $15.38 $51K 44,214
2026-11-04 van Houte Hans Chief Financial Officer Sale 10b5-1 −1,469 $16.20 $24K 42,745
2026-11-03 Ring Christine Chief Legal Officer Sale 10b5-1 −6,113 $25.83 $158K 4,406
2026-11-02 Ring Christine Chief Legal Officer Option exercise 10b5-1 +5,786 $8.72 $50K 21,121
2026-11-02 Ring Christine Chief Legal Officer Sale 10b5-1 −9,527 $25.74 $245K 11,594
2026-11-02 Ring Christine Chief Legal Officer Sale 10b5-1 −1,075 $26.76 $29K 10,519
2026-11-02 Ring Christine Chief Legal Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −5,786 105,465
2026-11-02 Hansen Gwenn Chief Scientific Officer Option exercise 10b5-1 +1,452 $1.86 $3K 124,904
2026-11-02 Hansen Gwenn Chief Scientific Officer Sale 10b5-1 −1,452 $26.80 $39K 123,452
2026-11-02 Hansen Gwenn Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −1,452 57,954
2026-10-30 van Houte Hans Chief Financial Officer Option exercise +3,750 43,916
2026-10-30 van Houte Hans Chief Financial Officer Option exercise +2,859 46,775
2026-10-30 van Houte Hans Chief Financial Officer Option exercise +3,573 50,348
2026-10-30 van Houte Hans Chief Financial Officer Sale −2,834 $26.28 $74K 47,514
2026-10-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −3,750 7,500
2026-10-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,859 17,150
2026-10-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −3,573 35,730
2026-10-30 Ring Christine Chief Legal Officer Option exercise +3,750 12,860
2026-10-30 Ring Christine Chief Legal Officer Option exercise +2,859 15,719
2026-10-30 Ring Christine Chief Legal Officer Option exercise +3,573 19,292

Page 1 of 32 · 632 trades